Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-42

Hi Fatt , Screen, Tech et al

Sorry forlate reply been out teaching.

I am a HUGEfan of the App and been along for the ride for a long time. I am also an RNwith a few decades of experience on the frontline or bedside in various health care settings A&E, Medical , Cancer, Aged Care ,prisons, remote and community health and in the last decade in Dementia and Neuro cognitive impairment. I have a long standing interest in pain management in people living with dementia and currently teach health students of all disciplines about dementia and on the effects of pain and behavior.

Fun fact : 87% of the Australian population hasat LEAST one chronic disease by age 65. Many have multiple co-morbidities. Wecan assume pain in many older people.

I canassure you pain management in the elderly is ” less than optimal” and if you do not manage pain -everything goes to hell and we see changed behaviors , agitation, aggression, calling out, delirium and in far too many cases ( see the Royal Commission) people given anti psychotics rather than simple analgesia.

I have readthrough the painchek website, the FAQ and ALL the research papers and advice refers to people living with dementia, cognitive impairment or infants.

In the FAQ’s.https://support.painchek.com/hc/en-us/articles/6078589320591-Does-it-Matter-if-the-Being-Assessed-is-Smiling

”As a reminder, PainChek is only approved and validated for with who cannot verbalise (e.g. those with dementia or cognitive impairment) and should not be used for those who are able to self-report, as this is thecurrent gold standard.”

There is no mention in the research on PainChek on drug seeking behaviour.

I have had several discussions with doctors nurses and care assistants about The Abbey Pain scale and Painchek -. I have had several baldy state “”It does not work!! .”” On further questioning it became obvious they had little to no experience nor adequate training in its use and in most- their knowledge of pain issues – to put it mildly.- less than optimal.

While I would dearly love to see future developments and capabilities some describe - we are not there yet and highly likely to be some years away until the research is done.

IMHO We should not attribute qualities or capabilities to the App that it simply does not have, because when used on the wrong population- When it fails to meet an impossible target it was Not designed for – eg drug seeking behaviour it can only fail and the reputation of the app undermined.

Our therapeutic targets are People living with dementia and infants. These areas are complex enough Lets keep the focus.

Can I request that someone contacts Prof Geoff Hughes and the team and seeks clarification from the experts on the actual capabilities of the app.

And for pity sakes folks ….please let it not be Nirmal :-D

Best wishes

Shrine.